KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allegro Microsystems (ALGM) Research & Development (2019 - 2025)

Allegro Microsystems has reported Research & Development over the past 7 years, most recently at $52.9 million for Q4 2025.

  • Quarterly Research & Development rose 22.07% to $52.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $197.9 million through Dec 2025, up 11.25% year-over-year, with the annual reading at $179.6 million for FY2025, 1.7% up from the prior year.
  • Research & Development was $52.9 million for Q4 2025 at Allegro Microsystems, up from $50.9 million in the prior quarter.
  • Over five years, Research & Development peaked at $52.9 million in Q4 2025 and troughed at $28.1 million in Q1 2021.
  • The 5-year median for Research & Development is $43.1 million (2023), against an average of $40.4 million.
  • Year-over-year, Research & Development surged 30.68% in 2022 and then dropped 2.43% in 2024.
  • A 5-year view of Research & Development shows it stood at $30.3 million in 2021, then surged by 30.68% to $39.6 million in 2022, then increased by 12.13% to $44.4 million in 2023, then dropped by 2.43% to $43.3 million in 2024, then grew by 22.07% to $52.9 million in 2025.
  • Per Business Quant, the three most recent readings for ALGM's Research & Development are $52.9 million (Q4 2025), $50.9 million (Q3 2025), and $46.5 million (Q2 2025).